Shanghai Junshi Biosciences Co., Ltd. (1877.HK)
- Previous Close
9.650 - Open
9.660 - Bid 9.720 x --
- Ask 9.740 x --
- Day's Range
9.510 - 9.830 - 52 Week Range
9.170 - 31.100 - Volume
1,270,984 - Avg. Volume
1,240,529 - Market Cap (intraday)
22.831B - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
-- - EPS (TTM)
-2.510 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
39.24
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.
www.junshipharma.comRecent News: 1877.HK
Performance Overview: 1877.HK
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1877.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1877.HK
Valuation Measures
Market Cap
22.67B
Enterprise Value
20.51B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.85
Price/Book (mrq)
1.23
Enterprise Value/Revenue
13.65
Enterprise Value/EBITDA
-8.34
Financial Highlights
Profitability and Income Statement
Profit Margin
-151.97%
Return on Assets (ttm)
-12.95%
Return on Equity (ttm)
-29.66%
Revenue (ttm)
1.5B
Net Income Avi to Common (ttm)
-2.28B
Diluted EPS (ttm)
-2.510
Balance Sheet and Cash Flow
Total Cash (mrq)
3.79B
Total Debt/Equity (mrq)
24.43%
Levered Free Cash Flow (ttm)
-2.11B
Research Analysis: 1877.HK
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 1877.HK
1877.HK does not have Company Insights